← Leaderboards
David J Waters
Purdue University West Lafayette
$915,419
Attributed
$915,419
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$915,419 · 3
By mechanism
M01$481,487 · 2
P30$433,932 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- Janet L Smith$23,647,105
- Richard F Borch$1,501,932
- Mark S Cushman$7,250,821
- Deborah W Knapp$3,970,345
- Philip L Fuchs$3,677,630
Others in their field
Top investigators on “Biomedical Facility”
- David Heimbrook · Leidos Biomedical Research, Inc.$269,207,281
- Mark S Klempner · Tufts Medical Center$133,377,807
- Joseph E Robertson · Oregon Health & Science University$129,896,064
- Lee Hamm · Tulane University Of Louisiana$114,986,978
- Peter Gordon Gillespie · Oregon Health And Science University$108,298,240
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$90,163,926
Research focus
Biomedical FacilityCytotoxicityDrug Design /Synthesis /ProductionDrug Screening /EvaluationTissue /Cell CultureCell LineAntineoplasticsNeoplasm /CancerOncologyGene ExpressionBlood PressureCardiovascular Disorder ChemotherapyChemopreventionClinical ResearchAce InhibitorsHuman SubjectHuman Therapy EvaluationPharmacogeneticsPhlebotomyMetabolism Disorder ChemotherapyHypertensionCholesterolStrokeCardiovascular Disorder Prevention
Grant awards (7)
CHOLESTEROL PHARMACOGENETICS STUDY$186,121
M01 · FY2005 · RR
HYPERTENSION AND RAMIPRIL PHARMACOGENETIC STUDY$34,907
M01 · FY2005 · RR
Cholesterol pharmacogenetics study$197,998
M01 · FY2004 · RR
Hypertension and ramipril pharmacogenetic study$62,461
M01 · FY2004 · RR
Core--Drug development$216,966
P30 · FY2002 · CA
Core--Drug development$216,966
P30 · FY2001 · CA
Core--Drug development$0
P30 · FY2000 · CA